Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 12, 2024 10:37 AM 1 min read

Why This Aramark Analyst Is Raising Forecasts After Mixed Q4 Results

by Priya Nigam Benzinga Staff Writer
Follow

ArticleFeaturedTickersList12345!!!

Aramark (NYSE:ARMK) Monday reported upbeat earnings for its fiscal fourth quarter.

The Philadelphia-based company announced a "material" share repurchase in fiscal 2025, for the first time in nearly eight years, according to Truist Securities.

Analyst Jasper Bibb maintained a Buy rating on Aramark, while raising the price target from $42 to $46.

Aramark Thesis: The company’s total revenues grew by 5% year-on-year to $4.417 billion, missing the consensus of $4.455 billion possibly due to incremental forex headwinds, Bibb said in the note.  

Check out other analyst stock ratings.

"Margin drivers included operating leverage, cost discipline and supply chain efficiencies," and the company reported adjusted earnings of 54 cents per share, ahead of consensus of 52 cents per shares, he added.

Aramark guided to organic growth of around 7.5%-9.5% in constant currency terms, implying full-year revenues in the range of $18.61 billion to $18.96 billion, versus consensus of $18.53 billion, net of a forex headwind of $95 million, the analyst stated.

While management announced the authorization of a share buyback program of $500 million, the earnings guidance "does not include any impact from potential share repurchase activity," Bibb further wrote.

Price Action: Shares of Aramark had declined by 0.62% to $38.44 in premarket trading on Tuesday.

Read More:

  • Food Company Aramark Posts Mixed Q4, Increases Dividend By 11% & More

Image: Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorEarnings BeatsLong IdeasPrice TargetReiterationAnalyst RatingsTrading IdeasStories That MatterTruist Securities
ARMK Logo
ARMKAramark
$39.37-6.68%
Overview
ARMK Logo
ARMKAramark
$39.37-6.68%
Overview
Comments
Loading...